The updated ALK testing guidelines from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology emphasize that both ALK immunohistochemistry and NGS-based methods are alternatives to ALK FISH for the detection of ALK status and selection of lung cancer patients for ALK TKI administration [21]. This evidence concerns the gene ALK and lung cancer.